Shares of OPKO Health (NASDAQ:OPK) were soaring 23% at 11:15 a.m. EDT on Tuesday after management disclosed on Monday it will provide coronavirus testing to all 32 teams in the National Football League. OPKO Health's wholly owned subsidiary, BioReference Labs is the nation's third-largest diagnostics laboratory. Fastest test result turnaround in the industry has landed the company impressive state, local, and sports contracts.